[Expression of bcl-2 in acute leukemia patients and its significance].
Jian Zf, Zhou Yh, Chen Fp
Abstract
Jian Zf, Zhou Yh, Chen Fp
Abstract
UNLABELLED: RT-PCR method was used to detect the expression level of bcl-2 gene in 38 patients of acute leukemia. RESULTS: Expression level of bcl-2 in the patients with clinical refractoriness increased more obviously than previously untreated and CR patients, and the expression level of bcl-2 was obviously correlated with clinical refractoriness(r = 0.83, P < 0.01), which indicated that high expression of bcl-2 was one of the factors in clinical refractoriness. It was also a sensitive method for predicting the effect of anti-tumor agents and prognosis in clinic work.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
UNLABELLED: RT-PCR method was used to detect the expression level of bcl-2 gene in 38 patients of acute leukemia. RESULTS: Expression level of bcl-2 in the patients with clinical refractoriness increased more obviously than previously untreated and CR patients, and the expression level of bcl-2 was obviously correlated with clinical refractoriness(r = 0.83, P < 0.01), which indicated that high expression of bcl-2 was one of the factors in clinical refractoriness. It was also a sensitive method for predicting the effect of anti-tumor agents and prognosis in clinic work.
Key concepts: Refractory period, Acute leukemia, Medicine, Leukemia, Clinical significance, Internal medicine, Oncology